WEREWOLF THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.66 USD | -1.33% |
|
+9.36% | +72.54% |
Chart calendar Werewolf Therapeutics, Inc.
ad47aa7f875.atBPCQQVnwDLUqvKWDHdTiuLCy17O6m7CjG_Vl2Z080.I7scYjEgzk68Ks3zGWWSOE3MfUwdfu_hbnT4CQnAt6odkTZPRlnrb4Zn4g~56f0efb405a59ffdfb0ef95f3385dedd
Upcoming events on Werewolf Therapeutics, Inc.
Past events on Werewolf Therapeutics, Inc.
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No - 4078 |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No - 4074 |
| 2024-03-13 09:20 am | Leerink Partners Global Biopharma Conference - Fireside Chat |
| 2024-03-07 07:00 am | Q4 2023 Earnings Release |
| 2023-11-29 08:20 am | Evercore ISI HealthCONx Conference - Fireside Chat |
| 2023-11-14 04:25 pm | Q3 2023 Earnings Release |
| 2023-11-03 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1058 |
| 2023-11-03 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 252 |
| 2023-11-03 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1074 |
| 2023-11-03 08:30 am | Society for Immunotherapy of Cancer Meeting |
| 2023-11-02 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1075 |
| 2023-11-02 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1059 |
| 2023-11-02 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 737 |
| 2023-09-27 03:35 pm | Cantor Global Healthcare Conference |
| 2023-09-18 10:00 am | R&D Day |
| 2023-09-11 12:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-10 07:10 am | Q2 2023 Earnings Release |
| 2023-06-21 09:00 am | Annual General Meeting |
| 2023-06-08 04:00 pm | Jefferies Global Healthcare Conference |
| 2023-05-17 11:00 am | RBC Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 16,4 12,0 37.12% | 19,9 20,4 -2.05% | 5,83 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -49,9 -46,8 -6.6% | -55,0 -53,2 -3.32% | -38,7 -44,7 13.34% | -69,3 |
|
EBIT Million USD | Released Forecast Spread | -22,4 | -50,1 -47,4 -5.6% | -56,1 -59,1 5.13% | -40,5 -43,3 6.38% | -62,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -50,0 -48,3 -3.48% | -53,8 -58,1 7.33% | -37,4 -39,4 5.13% | -56,6 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -202 -97,8 -106.49% | -53,8 -59,0 8.86% | -37,4 -41,2 9.38% | -59,2 |
|
EPS USD | Released Forecast Spread | -3,24 | -10,9 -6,36 -72.15% | -1,86 -2,08 10.49% | -1,05 -1,15 9.01% | -1,32 |
| Announcement Date | 26/02/21 | 24/03/22 | 23/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 4,15 7,50 -44.69% | 4,97 4,07 22.21% | 7,28 2,07 251.5% | 4,46 2,03 119.54% | 8,08 3,15 156.54% | 5,90 1,59 270.65% | 1,50 1,94 -22.78% | 1,46 | 1,46 | 1,46 | 1,46 |
|
EBITDA Million USD | Released Forecast Spread | -3,70 -11,4 67.48% | -6,71 -11,2 39.99% | -12,5 -16,6 24.8% | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -17,9 -15,2 -17.43% | -15,4 -16,2 5.35% | -15,0 -16,6 9.94% | -12,5 -15,9 21.13% | -13,2 -16,6 20.58% | -12,2 -15,6 21.4% | -6,07 -14,3 57.54% | -9,25 -14,1 34.24% | -13,0 -15,7 17.53% | -14,2 | -14,9 | -12,2 | -17,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,9 -16,2 -10.3% | -15,3 -15,3 -0.28% | -14,6 -16,1 9.35% | -11,9 -12,7 5.96% | -11,9 -16,3 26.81% | -12,0 -15,5 22.7% | -5,10 -13,9 63.32% | -8,29 -13,4 38.04% | -12,0 -14,0 14.47% | -13,2 | -13,8 | -9,79 | -15,6 |
|
Net income Million USD | Released Forecast Spread | -17,9 -15,0 -18.89% | -15,3 -16,9 9.45% | -14,6 -11,7 -24.74% | -11,9 -16,9 29.46% | -11,9 -17,2 30.81% | -12,0 -17,2 30.47% | -5,10 -14,6 64.97% | -8,29 -14,2 41.48% | -12,0 -15,9 24.39% | -13,6 | -14,3 | -11,4 | -16,5 |
|
EPS USD | Released Forecast Spread | -0,66 -0,53 -24.53% | -0,56 -0,62 8.94% | -0,53 -0,42 -25.2% | -0,40 -0,60 33.61% | -0,39 -0,55 28.57% | -0,34 -0,50 32% | -0,14 -0,41 65.85% | -0,23 -0,39 41.62% | -0,33 -0,43 23.96% | -0,35 | -0,32 | -0,23 | -0,34 |
| Announcement Date | 24/03/22 | 10/05/22 | 11/08/22 | 10/11/22 | 23/03/23 | 11/05/23 | 10/08/23 | 14/11/23 | 07/03/24 | - | - | - | - |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Werewolf Therapeutics, Inc.
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-29 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-28 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-28 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 2024-04-28 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-28 | MORPHOSYS AG: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HOWL Stock
- Calendar Werewolf Therapeutics, Inc.
